Private Profits

  • |

    Public Science, Private Billions, and the Invoice We Get Twice

    America’s favorite business plan is simple: the public pays for the research, infrastructure, and risk, then a private logo appears on the future with a checkout button attached. The internet, GPS, medicine, and space all become props in the same billionaire magic trick: public money builds the runway, private capital claims the plane, and ordinary people are told access is a premium experience. Somewhere, a newsroom raccoon is incorporating the lunch before selling it back by the sandwich.

    The problem is not that companies make useful things. The problem is treating taxpayer-funded breakthroughs as a free launchpad for private fortunes while the people who financed the launch become repeat customers. Public money, public lab, company formed, shares sold, billionaire wealth, public bill: that is not innovation policy so much as a tollbooth wearing a lab coat. If the public carries the risk, public value should not be an optional upgrade. We funded the runway; we are not trespassers on the plane.

  • |

    Wall Street’s New Favorite Dance: The Medicare Money Shuffle

    Picture the dance floor at a swanky Wall Street gala, where every beat syncs perfectly with Medicare’s cascading cash flow. It’s not a fundraiser—it’s a celebration, where taxpayer dollars pirouette elegantly into the pockets of America’s financial titans, who are somehow always in step with ‘limited competition’ and ‘ever-growing margins.’

    Think of it as a public funds tango; a dance we never learned, yet we’re forever financing. High prices are the new sheet music—every note drenched in champagne and caviar, while the taxpayers sit in the bleachers, wondering if they missed the invite or just funded it. Welcome to the ultimate societal shoulder shrug, where public funding becomes Wall Street’s limitless conga line!

End of content

End of content